ilmscore | Prediction Details
"I'm seeing margin Improvement has picking up so this is an indication that valuation time correction CFE time correction valuations had become comfortable and now the margins are again improving growth in earnings is also picking up part of it you can say that all the supply chain over Supply those have been adjusted part of it you can say that in the US the biocure ACT us doesn't want to fund any Chinese uh companies now right right that is where Indian companies who have good presence in cdmo they can really do well companies who have good presence in the US market Europe Market they can do well margins are improving so these are kind of indications that you know textile kard Pharma is another area where the Tailwind is there."
By Learn Stock Market 1M+ | January 24, 2025 | Pending
From video
All Season Portfolio Strategy for Long-Term Stock Market Success !! #Face2Face with Aniruddha Sarkar 00:51:06 - 00:51:48
Interpreted Prediction
The Indian Healthcare/Pharma sector is predicted to experience continued tailwinds, including margin improvement and earnings growth, driven by factors such as adjustments in supply chains and the US Biocure Act favoring Indian CDMO companies.

Prediction Details

Topic
Indian Healthcare/Pharma Sector

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.